Citation Tools
PDFRheumatoid arthritis
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response